Your Article Summary
See Latest ArticlesEfficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials
American Journal of Nephrology, 06/23/09
Cheng J et al. - The current cumulative evidence suggests that glucocorticoids have statistically significant effects on protecting renal function and reduction of proteinuria in patients with IgAN, but care should be taken for its gastrointestinal tract reaction. In general, glucocorticoids agents are a promising medication and should be investigated further.
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09
Eosinophil Count Is Positively Correlated with Albumin Excretion Rate in Men with Type 2 Diabetes
Clinical Journal of the American Society of Nephrology, 11/05/09
Renal artery stenosis: pathophysiology and treatment
Expert Review of Cardiovascular Therapy , 11/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09